Representative before the EPO

Employment test 501 - 1000 employees
Company dna marks and clerk llp
operating since 1887
Headquarter in London and 16 offices
active in Legal Services, IP Consulting, and Matchmaking and Trading

Angus Chisholm Fairbairn has worked on the following 120 EPO patent applications which have been published in the last five years:

EP10710915

A ONE POT AND SINGLE STEP HYDROLYTIC PROCESS FOR THE CONVERSION OF LIGNOCELLULOSE INTO VALUE ADDED CHEMICALS

IPC classification:
C13K 13/00
Applicant:
Council of Scientific & Industrial Research
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP11776597

NOVEL CATIONIC AMPHIPHILES WITH MANNOSE-MIMICKING HEAD-GROUPS AND A PROCESS FOR THE PREPARATION THEREOF

IPC classification:
A61K 31/16, A61P 43/00, C07C 231/02, C07C 237/10
Applicant:
Council of Scientific & Industrial Research
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
PATENT GRANTED
EP11776854

AN IMPROVED PROCESS FOR THE EPOXIDATION OF FATTY ACIDS, THEIR ESTERS AND MIXTURES THEREOF

IPC classification:
B01J 23/28, B01J 27/14, B01J 32/00, C11C 3/00
Applicant:
Council of Scientific & Industrial Research
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP11782228

SIZE-EFFICIENT DRUG-DELIVERY DEVICE

IPC classification:
A61M 5/145
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP13153934

Drug delivery device with electrically controlled volume changing means

IPC classification:
A61B 5/01, A61B 5/145, A61M 5/142, A61M 5/145, A61M 5/172
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP11720857

PROCESS FOR THE PREPARATION OF HIGH VOLTAGE NANO COMPOSITE CATHODE (4.9V) FOR LITHIUM ION BATTERIES

IPC classification:
C01B 25/26, C01B 25/45, H01M 4/58, H01M 4/62
Applicant:
Council of Scientific & Industrial Research
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP11788600

COMPOSITION CONTAINING INJECTABLE SELF-HARDENED APATITE CEMENT

IPC classification:
A61L 24/00, A61L 27/42
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP11788601

A METHOD OF CONVERTING LIMESTONE INTO TRI-CALCIUM PHOSPHATE AND TETRA-CALCIUM PHOSPHATE POWDER SIMULTANEOUSLY.

IPC classification:
C01B 25/32
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
PATENT GRANTED
EP12709702

DOSAGE REGIMEN, MEDICATION DISPENSING PACKAGE AND USES THEREOF FOR THE TREATMENT OF MAJOR DEPRESSIVE DISORDER

IPC classification:
A61K 31/42, A61P 25/24
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP10833266

METHOD FOR MANUFACTURING A 6-SUBSTITUTED-1-METHYL-1H-BENZIMIDAZOLE DERIVATIVE, AND MANUFACTURING INTERMEDIATE FROM SAID METHOD

IPC classification:
A61K 31/427, A61P 3/10, A61P 29/00, A61P 35/00, A61P 43/00, C07C 213/02, C07C 217/90, C07D 277/20, C07D 277/34, C07D 417/12
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
APPLICATION WITHDRAWN
EP13166147

Selective apoptotic induction in cancer cells including activation of procaspase-3

IPC classification:
A61K 31/495, A61P 35/00, C07D 295/15, G01N 33/574
Applicant:
Board of Trustees of the University of Illinois
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP12777084

PHENYL PYRROLE DERIVATIVE CRYSTAL

IPC classification:
A61K 31/497, A61P 3/10, C07D 413/14
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11744791

SUSTAINED-RELEASE SOLID PREPARATION FOR ORAL USE

IPC classification:
A61K 9/16, A61K 31/403, A61K 31/4745, A61P 7/02
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP11744790

SUSTAINED-RELEASE SOLID PREPARATION FOR ORAL USE

IPC classification:
A61K 9/22, A61K 31/403, A61K 31/4745, A61P 7/02
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP12804846

PHOSPHORIC ACID ESTER DERIVATIVE

IPC classification:
A61K 31/661, A61P 1/04, A61P 9/10, A61P 11/00, A61P 11/02, A61P 11/06, A61P 17/00, A61P 17/04, A61P 17/06, A61P 19/02, A61P 21/00, A61P 25/00, A61P 27/14, A61P 29/00, A61P 37/02, A61P 37/06, A61P 37/08, C07F 9/09
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP12811023

PRODUCT QUALITY CONTROL METHOD

IPC classification:
A61J 3/06, A61J 3/07, G01N 33/15
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP12822801

PHARMACEUTICAL COMPOSITION CONTAINING DIAMINE DERIVATIVE

IPC classification:
A61K 9/20, A61K 9/48, A61K 31/444, A61K 47/12, A61K 47/32, A61K 47/38, A61P 7/02, A61P 43/00
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP13722048

SELECTIVE EXTRACTION OF POTASSIUM CHLORIDE FROM SCHOENITE END LIQUOR EMPLOYING TARTARIC ACID AS SAFE, BENIGN AND RECYCLABLE EXTRACTANT

IPC classification:
C01D 3/06, C01D 3/08
Applicant:
Council of Scientific & Industrial Research
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12832990

COMPOSITIONS AND METHODS FOR MOLECULAR IMAGING OF OXYGEN METABOLISM

IPC classification:
A61K 9/10, G01N 15/06, G01N 33/49
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP12857502

OPTICAL RESOLUTION METHOD FOR BICYCLIC COMPOUND USING ASYMMETRIC CATALYST

IPC classification:
C07B 57/00, C07B 61/00, C07C 45/85, C07C 49/627, C07C 227/12, C07C 229/32
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP12858308

METHOD FOR PRODUCING NEURAMINIC ACID DERIVATIVE

IPC classification:
A61K 31/351, A61P 31/16, C07D 309/14, C07D 309/28, C07D 405/06
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP12860237

KNEADING-TYPE ANTISTATIC AGENT, THERMOPLASTIC RESIN COMPOSITION INCLUDING SAID AGENT, AND MOLDED ARTICLE

IPC classification:
C08F 290/06, C08F 299/02, C08L 55/00, C08L 101/00, C09K 3/16
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP13740881

CHROMONE DERIVATIVE HAVING OSTEOGENESIS PROMOTING EFFECT

IPC classification:
A61K 31/397, A61K 31/4025, A61K 31/453, A61K 31/454, A61K 31/4545, A61K 31/496, A61K 31/497, A61K 31/5377, A61P 19/08, A61P 19/10, C07D 311/22, C07D 405/04, C07D 405/14, C07D 417/14
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP12796945

METHOD FOR PRODUCING BICYCLIC COMPOUND VIA CLAISEN REARRANGEMENT

IPC classification:
B01J 31/02, C07B 61/00, C07C 45/41, C07C 45/45, C07C 45/48, C07C 45/51, C07C 47/21, C07C 49/727, C07C 51/38, C07C 57/03, C07C 227/18, C07C 227/22, C07C 229/32
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP13713977

PHARMACEUTICAL DOSAGE FORM

IPC classification:
A61K 9/16
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP13746373

CYCLOALKANE DERIVATIVE

IPC classification:
A61K 31/427, A61K 31/433, A61K 31/506, A61P 19/02, A61P 19/06, A61P 21/02, A61P 25/04, A61P 25/06, A61P 25/08, A61P 25/22, A61P 29/00, A61P 43/00, C07D 285/08, C07D 401/12, C07D 403/12, C07D 417/12
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
PATENT GRANTED
EP13720085

ENHANCED INFUSION-SITE PAIN-REDUCTION FOR DRUG-DELIVERY DEVICES

IPC classification:
A61M 1/04, A61M 1/36, A61M 5/142, A61M 5/158, A61M 5/42
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP14779687

SOLID COMPOSITION OF AMINO CARBOXYLATE SALT

IPC classification:
A61K 9/20, A61K 31/197, A61K 47/10, A61K 47/12, A61K 47/14, A61K 47/26, A61K 47/36, A61K 47/38, A61P 25/00, A61P 25/04
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP12186361

Fused substituted aminopyrrolidine derivative

IPC classification:
C07D 209/02, C07D 209/56, C07D 401/04, C07D 491/052
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13720086

FLUID-CONNECTION MECHANISM FOR PATCH-PUMPS

IPC classification:
A61M 5/142, A61M 5/158
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP13712043

2'- SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT

IPC classification:
A61K 31/706, A61P 31/16, C07H 19/23
Applicant:
Gilead Sciences Inc
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
PATENT GRANTED
EP11814730

CRYSTAL OF ANTI-BACTERIAL COMPOUND

IPC classification:
A61K 31/4709, A61P 31/04, C07D 401/04
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13775061

OPTICAL RESOLUTION METHOD FOR BICYCLIC COMPOUND USING ENZYME

IPC classification:
C07B 57/00, C07C 45/85, C07C 49/627, C07C 227/12, C07C 229/32, C12P 41/00
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
PATENT GRANTED
EP12796329

METHOD FOR PRODUCING BICYCLIC COMPOUND VIA IMINIUM SALT

IPC classification:
C07B 61/00, C07C 45/41, C07C 45/48, C07C 45/52, C07C 49/433, C07C 51/38, C07C 211/63, C07C 227/22, C07C 227/34, C07C 229/32, C07C 251/30
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP12754741

DIPYRIDYLAMINE DERIVATIVE AS GLUCOKINASE ACTIVATOR

IPC classification:
A61K 31/444, A61K 31/506, A61P 3/10, A61P 9/00, A61P 9/10, A61P 13/12, A61P 25/02, A61P 27/02, A61P 43/00, C07D 401/14, C07D 413/14
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13726936

ANTIVIRAL COMPOUNDS INHIBITORS OF HCV NS5B

IPC classification:
A61K 31/4188, C07D 491/052
Applicant:
Gilead Pharmasset LLC
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
PATENT GRANTED
EP13726937

ANTIVIRAL COMPOUNDS WITH AN IMIDAZOLE - BIPHENYL - IMIDAZOLE CORE

IPC classification:
A61K 31/4178, A61P 31/14, C07D 403/14
Applicant:
Gilead Sciences Inc
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP14175570

Antiviral compounds

IPC classification:
A61K 31/4178, A61K 31/4188, A61P 31/12, C07D 401/14, C07D 403/04, C07D 403/14, C07D 409/14
Applicant:
Gilead Pharmasset LLC
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13729569

SOLID FORMS OF AN ANTIVIRAL COMPOUND

IPC classification:
A61K 31/4178, A61P 31/12, C07D 471/08
Applicant:
Gilead Pharmasset LLC
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP13729208

SYNTHESIS OF ANTIVIRAL COMPOUND

IPC classification:
C07D 403/04, C07D 403/14
Applicant:
Gilead Pharmasset LLC
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11805616

METHOD FOR PRODUCING SMALL SIZE TITANIUM OXIDE PARTICLES

IPC classification:
C01G 23/053
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13804804

PIPERIDINYLPYRAZOLOPYRIDINE DERIVATIVE

IPC classification:
A61K 31/4545, A61K 31/4709, A61K 31/497, A61K 31/501, A61K 31/506, A61P 3/06, A61P 9/10, A61P 13/12, A61P 43/00, C07D 471/04
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13752940

HIGH REFRACTIVE INDEX (METH) ACRYLATES

IPC classification:
C07C 67/14, C07C 69/54
Applicant:
Council of Scientific & Industrial Research
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
PATENT GRANTED
EP13781806

AIR CONDITIONER

IPC classification:
F24F 1/00, F24F 11/02
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
PATENT GRANTED
EP14823864

METHOD FOR PRODUCING OPTICALLY ACTIVE BICYCLIC -AMINO ACID DERIVATIVE

IPC classification:
C07B 57/00, C07B 61/00, C07C 201/12, C07C 201/16, C07C 205/50, C07C 227/00, C07C 227/42, C07C 229/32, C07C 253/10, C07C 253/30, C07C 253/34, C07C 255/47
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
PATENT GRANTED
EP13739324

INHIBITORS OF HEPATITIS C VIRUS

IPC classification:
A61K 31/4995, A61P 31/14, C07D 491/18
Applicant:
Gilead Sciences Inc
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
PATENT GRANTED
EP14175539

Antiviral compounds

IPC classification:
A61K 31/4184, A61K 31/4188, A61P 31/12, C07D 401/14, C07D 471/08
Applicant:
Gilead Pharmasset LLC
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
PATENT GRANTED
EP13750474

SYNTHESIS OF AN ANTIVIRAL COMPOUND

IPC classification:
C07D 333/36, C07D 409/12
Applicant:
Gilead Sciences Inc
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13750249

SYNTHESIS OF AN ANTIVIRAL COMPOUND

IPC classification:
C07D 307/20, C07D 409/12
Applicant:
Gilead Sciences Inc
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
PATENT GRANTED
EP13750475

SOLID FORMS OF AN ANTIVIRAL COMPOUND

IPC classification:
A61K 31/381, A61P 31/12, C07D 409/12
Applicant:
Gilead Sciences Inc
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11769396

PROCESS FOR HIGH CONCENTRATION CATION EXCHANGE METATHESIS

IPC classification:
B01J 39/04, C01C 3/00, C01C 3/08, C01C 3/10
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP13729109

BLUE INORGANIC COLOURANTS/PIGMENTS AND PROCESS FOR PREPARATION THEREOF

IPC classification:
C01B 33/24, C09C 1/28
Applicant:
Council of Scientific & Industrial Research
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP13832279

HYDROMORPHONE HYDROCHLORIDE-CONTAINING ORAL SUSTAINED-RELEASE PHARMACEUTICAL COMPOSITION

IPC classification:
A61K 9/20, A61K 9/26, A61K 31/485, A61K 47/10, A61K 47/14, A61K 47/26, A61K 47/38, A61P 25/04
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP13783679

DIAGNOSTIC AGENTS WITH ENHANCED SENSITIVITY/SPECIFICITY

IPC classification:
A61K 49/00
Applicant:
Ben Gurion University of The Negev Research and Development Authority
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP13843105

PRODUCING FRACTIONATED AND UPGRADED FUELS FROM BIOMASS

IPC classification:
C10G 45/00, C10L 1/18, C10L 3/06
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP11828999

CYCLOHEXANE DERIVATIVE COMPOUND

IPC classification:
A61K 31/495, A61K 31/496, A61P 1/00, A61P 1/04, A61P 1/10, A61P 1/14, C07D 213/64, C07D 213/84, C07D 241/04, C07D 263/22, C07D 295/12, C07D 295/135, C07D 401/12
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13845596

ANTIBODY-DRUG CONJUGATE

IPC classification:
A61K 31/4745, A61K 31/48, A61K 39/395, A61P 35/00, C07K 16/28
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP13815595

PROCESS FOR THE PREPARATION OF (1S,4S,5S)-4-BROMO-6-OXABICYCLO[3.2.1]OCTAN-7-ONE

IPC classification:
C07D 307/94, C07D 513/04
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP13821730

HISTIDINYLATED CATIONIC AMPHIPHILES, PROCESS FOR PREPARATION THEREOF AND THEIR LIPOSOMAL FORMULATION

IPC classification:
A61K 31/4172, A61P 35/00, C07D 233/64
Applicant:
Council of Scientific & Industrial Research
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
PATENT GRANTED
EP13819144

ANTIVIRAL COMPOUNDS

IPC classification:
A61K 31/4188, A61P 31/12, C07D 491/04
Applicant:
Gilead Sciences Inc
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
PATENT GRANTED
EP14708335

ELASTIC MACRO POROUS SCAFFOLD AND A PROCESS FOR THE PREPARATION THEREOF

IPC classification:
A61L 27/56, B01J 37/32
Applicant:
Council of Scientific & Industrial Research
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP11852108

ELECTRODE AND ELECTRICAL STORAGE DEVICE FOR LEAD-ACID SYSTEM

IPC classification:
H01M 4/14, H01M 4/16, H01M 4/36, H01M 4/583, H01M 4/62, H01M 10/06
Applicant:
Commonwealth Scientific and Industrial Research Organisation (CSIRO)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP15174323

METHOD FOR PRODUCING NEURAMINIC ACID DERIVATIVE

IPC classification:
C07D 309/28
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP15174321

METHOD FOR PRODUCING NEURAMINIC ACID DERIVATIVE

IPC classification:
C07D 309/28, C07D 407/06
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
The patent has been granted
EP14763747

DRUG FOR RESPIRATORY DISEASES

IPC classification:
A61K 31/506, A61P 11/00, A61P 11/06, A61P 11/08, A61P 11/14
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP14765144

BENZOTHIOPHENE DERIVATIVE

IPC classification:
A61K 31/4709, A61K 31/496, A61K 31/5377, A61K 31/675, A61P 3/04, A61P 25/00, A61P 25/14, A61P 25/16, A61P 25/18, A61P 25/22, A61P 25/24, A61P 25/28, A61P 25/30, A61P 25/32, A61P 25/36, C07D 409/12, C07D 409/14
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP14723582

MACROCYCLIC AND BICYCLIC INHIBITORS OF HEPATITIS C VIRUS

IPC classification:
A61K 31/437, A61K 31/4985, A61K 31/519, A61P 31/14, C07D 498/22
Applicant:
Gilead Sciences Inc
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP14770519

TERPENOID DERIVATIVE

IPC classification:
A61K 31/56, A61K 31/58, A61P 1/16, A61P 9/10, A61P 11/00, A61P 11/06, A61P 13/02, A61P 13/12, A61P 21/00, A61P 25/14, A61P 25/16, A61P 25/28, A61P 27/02, A61P 27/06, A61P 27/12, A61P 27/14, C07J 63/00, C12N 1/14, C12P 33/00, C12P 33/06
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP14774738

METHOD FOR PRODUCING (1S,4S,5S)-4-BROMO-6-OXABICYCLO[3.2.1]OCTAN-7-ONE

IPC classification:
A61K 31/437, A61P 7/02, C07D 493/08
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP14774515

PROCESSES FOR PREPARING OPTICALLY ACTIVE DIAMINE DERIVATIVES

IPC classification:
A61K 31/444, A61P 7/02, A61P 43/00, C07B 53/00, C07C 269/00, C07C 271/24, C07C 303/28, C07C 303/34, C07C 307/08, C07C 309/66, C07C 309/73, C07D 285/14, C07D 513/04
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
The patent has been granted
EP14724520

NOVEL CHROMONE ALKALOID DYSOLINE FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISORDERS

IPC classification:
A61K 31/4523, A61P 29/00, A61P 35/00, C07D 311/24
Applicant:
Council of Scientific & Industrial Research
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP14782674

DIPYRROMETHENE CRYSTAL AND METHOD FOR MANUFACTURING SAME

IPC classification:
A61K 31/40, A61P 43/00, C07D 207/34
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP15175764

DERIVATIVES OF 1-(BENZIMIDAZOL-2-YL)-4-(5-PHENYL-1,2,4-OXADIAZOL-3-YL)-BENZENE USEFUL AS ANTICANCER AGENTS AND PROCESS FOR THE PREPARATION THEREOF

IPC classification:
A61K 31/4245, A61P 35/00, C07D 413/10
Applicant:
Council of Scientific & Industrial Research
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
PATENT GRANTED
EP15180635

ANTIVIRAL COMPOUNDS

IPC classification:
A61K 31/4178, A61K 31/4184, A61K 31/4188, A61K 45/06, A61P 31/12, C07D 401/14, C07D 403/04, C07D 403/14, C07D 405/14, C07D 409/14, C07D 413/04, C07D 417/04, C07D 417/14, C07D 471/08, C07D 495/04, C07F 5/02
Applicant:
Gilead Pharmasset LLC
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP14803860

ANTIMICROBIAL AND ANTIVIRAL POLYMERIC MATERIALS

IPC classification:
A61K 33/34, A61L 2/238, A61L 9/01, B29C 55/00, D02G 3/00
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP13819083

TETRAHYDRO-2H-PYRANO[3,2-C]ISOCHROMENE-6-ONES AND ANALOGS FOR THE TREATMENT OF INFLAMMATORY DISORDERS

IPC classification:
A61K 31/35, A61P 19/02, C07D 493/04
Applicant:
Council of Scientific & Industrial Research
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP14803528

ANTIMICROBIAL AND ANTIVIRAL POLYMERIC MATERIALS

IPC classification:
A01N 25/10, A01N 59/20, A61K 33/34
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP14738643

AUTOIMMUNE-INDUCED GLUTAMATERGIC RECEPTOR DYSFUNCTION METHODS AND TREATMENTS

IPC classification:
A61K 31/192, A61K 31/198, A61K 31/496, A61K 45/06, A61P 25/00
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP14817788

METHOD FOR PRODUCING TRICYCLIC HETEROCYCLIC COMPOUND

IPC classification:
C07D 471/06
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP13177681

Intermediate for producing bicyclic y-amino acid derivative

IPC classification:
C07C 49/627, C07C 229/32, C07C 323/58
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12710564

PERYLENEBISIMIDE - POLYESTER BLEND

IPC classification:
C08G 63/199, C08G 63/91, C08K 5/3437, C09K 11/06, H01L 51/50
Applicant:
Council of Scientific & Industrial Research
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12175765

Olmesartan medoxomil for preventing or treating angiogenic eye diseases

IPC classification:
A61K 31/4178, A61K 45/06, A61P 27/02, A61P 43/00
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11734446

BIOFILM RESISTANT MATERIALS

IPC classification:
A01N 59/20, A61L 15/44, A61L 27/54, A61L 29/16, A61L 31/16
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14839943

METHOD FOR PRODUCING PYRROLE DERIVATIVE, AND INTERMEDIATE THEREOF

IPC classification:
C07B 57/00, C07D 207/456, C12P 41/00
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP14704501

COMBINATION FORMULATION OF TWO ANTIVIRAL COMPOUNDS

IPC classification:
A61K 9/16, A61K 9/20, A61K 31/4188, A61K 31/513
Applicant:
Gilead Pharmasset LLC
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP14786729

PROCESS FOR THE SYNTHESIS OF NITROGEN-DOPED CARBON ELECTRO-CATALYST

IPC classification:
C01B 31/02, H01M 4/96
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP15198230

MEDICINE FOR PREVENTION OF AND TREATMENT FOR ARTERIOSCLEROSIS AND HYPERTENSION

IPC classification:
A61K 31/4178, A61K 31/4422, A61K 31/455, A61K 45/06, A61P 9/00, A61P 9/10, A61P 9/12, A61P 13/12, A61P 43/00
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP11801000

PROCESS FOR PREPARATION OF OPTICALLY ACTIVE DIAMINE DERIVATIVE SALT

IPC classification:
C07C 51/43, C07C 55/07, C07C 269/08, C07C 271/24
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
PATENT GRANTED
EP11744792

SUSTAINED-RELEASE SOLID PREPARATION FOR ORAL USE

IPC classification:
A61K 9/16, A61K 9/22, A61K 31/403, A61K 31/4745, A61K 47/10, A61K 47/26, A61K 47/32, A61K 47/36, A61K 47/38
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
PATENT GRANTED
EP14849690

SELECTIVE PRODUCTION METHOD FOR D-MANNITOL -FORM CRYSTAL USING SPRAY-DRYING METHOD

IPC classification:
C07C 29/76, C07C 31/26
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP11756252

METHOD FOR IMPROVING DISSOLVABILITY OF ANTICOAGULANT

IPC classification:
A61K 9/16, A61K 9/20, A61K 9/32, A61K 9/36, A61K 31/444, A61K 47/10, A61K 47/32, A61K 47/36, A61K 47/38, A61P 7/02
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
PATENT GRANTED
EP11826892

A METHOD OF PREPARING CRYSTALS OF A SUBSTITUTED CYCLOALKENE DERIVATIVE

IPC classification:
A61K 31/357, A61P 29/00, A61P 31/04, A61P 31/12, A61P 43/00, C07D 317/72
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
PATENT GRANTED
EP11776595

ORGANOMETALLIC MOLYBDENUM ACETYLIDE DIOXO COMPLEX AND PROCESS FOR THE PREPARATION THEREOF

IPC classification:
C07B 33/00, C07F 17/00
Applicant:
Council of Scientific & Industrial Research
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11845734

PYRROLE DERIVATIVE AND PROCESS FOR PRODUCTION THEREOF

IPC classification:
A61K 31/40, C07B 53/00, C07D 207/335, C07D 413/06
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14815066

COMPOUNDS FOR THE TREATMENT OF DIABETES AND DISEASE COMPLICATIONS ARISING FROM SAME

IPC classification:
A61K 31/055, A61K 31/08, A61P 3/10
Applicant:
Ben Gurion University of The Negev Research and Development Authority
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP12706943

SUBSTITUTED 1, 2, 3, 4-TETRAHYDROQUINOLIN-7-YL CARBAMATES AS ACETYLCHOLINESTERASE INHIBITORS FOR TREATMENT OF ALZHEIMER'S DISEASE

IPC classification:
A61K 31/47, A61P 25/00, C07D 215/20
Applicant:
Council of Scientific & Industrial Research
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14869320

5-HYDROXY-4-(TRIFLUOROMETHYL)PYRAZOLOPYRIDINE DERIVATIVE

IPC classification:
A61K 31/4545, A61K 31/497, A61K 31/501, A61K 31/506, A61P 3/06, A61P 9/04, A61P 9/10, A61P 13/12, A61P 43/00, C07D 471/04
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP14822040

SYNTHESIS OF A MACROCYCLIC HCV NS3 INHIBITING TRIPEPTIDE

IPC classification:
C07K 5/12
Applicant:
Gilead Sciences Inc
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP14874745

ANTI-TROP2 ANTIBODY-DRUG CONJUGATE

IPC classification:
A61K 31/4745, A61K 39/395, A61K 47/48, A61P 35/00, C07K 16/28, C12N 15/09
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Applicant:
Sapporo Medical University
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP14824322

CRYSTALLINE FORMS OF A MACROCYCLIC HCV NS3 INHIBITING TRIPEPTIDE

IPC classification:
C07K 5/12
Applicant:
Gilead Sciences Inc
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP16166277

COMBINATION OF MORPHINAN COMPOUNDS AND ANTIDEPRESSANT FOR THE TREATMENT OF PSEUDOBULBAR AFFECT, NEUROLOGICAL DISEASES, INTRACTABLE AND CHRONIC PAIN AND BRAIN INJURY

IPC classification:
A61K 31/135, A61K 31/137, A61K 31/138, A61K 31/15, A61K 31/343, A61K 31/4525, A61K 31/485, A61K 45/06, A61P 25/00
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP16163718

MORPHINAN COMPOUNDS

IPC classification:
A61K 31/439, A61P 11/14, C07B 59/00, C07D 471/08
Applicant:
Concert Pharmaceuticals Inc
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP16711723

TOLL-LIKE RECEPTOR MODULATING 4,6-DIAMINO-PYRIDO[3,2-D]PYRIMIDINE COMPOUNDS

IPC classification:
A61K 31/519, A61P 29/00, A61P 31/12, A61P 35/00, A61P 37/00, C07D 471/04
Applicant:
Gilead Sciences Inc
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
The patent has been granted
EP15714016

PHARMACEUTICAL COMPOSITION COMPRISING BRINZOLAMIDE

IPC classification:
A61K 9/00, A61K 31/542, A61K 47/26, A61K 47/34, A61P 27/06
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP15743738

ANTI-HER2 ANTIBODY-DRUG CONJUGATE

IPC classification:
A61K 31/4745, A61K 39/395, A61P 35/00, C07D 491/052, C07K 16/28
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP15171662

INFUSION SET

IPC classification:
A61M 5/142, A61M 39/10
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP15706602

SUBSTITUTED TRIAZOLOBENZODIAZEPINES

IPC classification:
A61K 31/55, A61P 35/00, C07D 487/04
Applicant:
Concert Pharmaceuticals Inc
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP15752236

AMINOPYRAZOLONE DERIVATIVE

IPC classification:
A61K 31/4152, A61K 31/4155, A61K 31/423, A61K 31/4439, A61K 31/444, A61K 31/4709, A61K 31/5377, A61K 31/538, A61P 35/00, A61P 43/00, C07D 231/50, C07D 401/04, C07D 401/12, C07D 401/14, C07D 403/12, C07D 405/12, C07D 413/12
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP11744690

IMIDAZOLE DERIVATIVE

IPC classification:
A61K 31/4164, A61P 1/04, A61P 9/14, A61P 11/02, A61P 11/06, A61P 17/00, A61P 17/02, A61P 17/04, A61P 19/02, A61P 21/00, A61P 25/00, A61P 27/14, A61P 29/00, A61P 35/00, A61P 37/00, A61P 37/06, A61P 37/08, A61P 43/00, C07D 233/64, C07D 233/90
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15714294

USE OF A FACTOR XA INHIBITOR FOR TREATING AND PREVENTING BLEEDING EVENTS AND RELATED DISORDERS IN PATIENTS HAVING SENSITIVITY TO VITAMIN K ANTAGONISTS USED AS ANTICOAGULANTS

IPC classification:
A61K 31/444, A61K 31/727, A61K 45/06, A61P 7/02
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP15776810

(ANTI-HER2 ANTIBODY)-DRUG CONJUGATE

IPC classification:
A61K 31/4745, A61K 39/395, A61P 35/00, C07K 5/072, C07K 5/083, C07K 5/103, C07K 7/06, C07K 16/32
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP15719011

ANTI-HER3 ANTIBODY-DRUG CONJUGATE

IPC classification:
A61K 47/50
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP16193142

METHODS OF PRODUCING 4-CYCLOALKYLOXYBENZENESULFONAMIDES

IPC classification:
C07D 285/08, C07D 401/12, C07D 403/12, C07D 417/12
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP15747596

PROCESSES FOR PREPARING ANTIVIRAL COMPOUNDS

IPC classification:
A61K 31/4188, C07D 491/052
Applicant:
Gilead Pharmasset LLC
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP15730621

SOLID FORMS OF AN ANTIVIRAL COMPOUND

IPC classification:
A61K 31/4188, A61P 31/00, C07D 491/052
Applicant:
Gilead Pharmasset LLC
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP15837719

PHARMACEUTICAL COMPOSITION FOR INHIBITING FORMATION OF THROMBI AND EMBOLI AFTER PLACEMENT OF STENT

IPC classification:
A61K 31/4365, A61K 31/437, A61K 31/4465, A61K 31/4709, A61K 31/519, A61K 31/616, A61K 45/00, A61P 7/02
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
Request for examination was made
EP17157692

CRYSTAL OF PYRROLE DERIVATIVE AND METHOD FOR PRODUCING THE SAME

IPC classification:
A61K 31/40, A61P 43/00, C07D 207/34
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
Request for examination was made
EP15840177

SUSTAINED-RELEASE PHARMACEUTICAL COMPOSITION FOR TREATING AND PREVENTING OPHTHALMIC DISEASES

IPC classification:
A61K 9/52, A61K 31/277, A61K 31/336, A61K 47/34, A61P 1/16, C12P 33/06
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
Request for examination was made
EP15862635

4-FLUORO-THIO-CONTAINING INHIBITORS OF APP2, COMPOSITIONS THEREOF AND METHOD OF USE

IPC classification:
A01N 43/38
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
Request for examination was made
EP15816539

PRESERVATIVE-FREE TREPROSTINIL FORMULATIONS AND METHODS AND DEVICES FOR USE WITH SAME

IPC classification:
A61K 9/00, A61K 31/5575, A61P 9/12
Agent:
Angus Chisholm Fairbairn, Marks & Clerk LLP
Status:
Request for examination was made

Please Sign in to use this feature